REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: SEER-MEDICARE ANALYSIS

被引：0
|
作者：
Hamlin, P. [1 ]
Satram-Hoang, S. [2 ]
Reyes, C. [3 ]
Hoang, K. [2 ]
Guduru, S. [2 ]
Skettino, S. [3 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] QD Res Inc, Granite Bay, CA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P843
引用
收藏
页码：353 / 353
页数：1
相关论文
共 50 条
  • [21] Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    ADVANCES IN THERAPY, 2024, 41 (03) : 1226 - 1244
  • [22] Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare dataset
    Luan, Danny
    Wu, Yiyuan
    Goldstein, Jordan
    Rutherford, Sarah
    Leonard, John P.
    Martin, Peter
    LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 1850 - 1859
  • [23] Burden of illness and outcomes in second-line large B-cell lymphoma treatment: real-world analysis of Medicare beneficiaries
    Kilgore, Karl M.
    Mohammadi, Iman
    Wong, Anny C.
    Snider, Julia T.
    Cheng, Paul
    Schroeder, Amy
    Patel, Anik R.
    FUTURE ONCOLOGY, 2021, 17 (35) : 4837 - 4847
  • [24] Real-World Treatment Patterns, Healthcare Resource Utilization, Costs, and Survival Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma (DLBCL)
    Garg, Mahek
    Huntington, Scott F.
    Puckett, Justin
    Kamal-Bahl, Sachin
    Raut, Monika
    Ryland, Katherine Elizabeth
    Doshi, Jalpa
    BLOOD, 2022, 140 : 10814 - 10815
  • [25] Diffuse Large B-Cell Lymphoma in the Elderly: Real World Outcomes of Immunochemotherapy in Asian Population
    Byun, Ja Min
    Lee, Jeong-Ok
    Kang, Beodeul
    Kim, Ji-Won
    Kim, Se Hyun
    Kim, Jin Won
    Kim, Yu Jung
    Lee, Keun-Wook
    Bang, Soo-Mee
    Lee, Jong Seok
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (09): : 503 - 510
  • [26] Evaluation of the Prognostic Utility of Bone Marrow Biopsy in Diffuse Large B-Cell Lymphoma: A SEER-Medicare Linked Database Analysis
    Luan, Danny
    Wu, Yiyuan
    Goldstein, Jordan S.
    Rutherford, Sarah C.
    Leonard, John P.
    Martin, Peter
    BLOOD, 2020, 136
  • [27] A SEER-Medicare Analysis of the Cost of Disease Progression After Frontline R-CHOP in Diffuse Large B-Cell Lymphoma
    Burke, John M.
    Wang, Rongrong
    Hossain, Farah
    Li, Jia
    Masaquel, Anthony
    Qiheng, Summera
    Matasar, Matthew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S360 - S360
  • [28] REAL-WORLD TREATMENT PATTERNS AND COSTS IN RELAPSED AND REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE UNITED STATES
    Mutebi, A.
    Jun, M.
    Flores, C.
    Wang, Z.
    Wang, A.
    Elliot, B.
    Navarro, F. R.
    Kalsekar, A.
    VALUE IN HEALTH, 2022, 25 (07) : S394 - S394
  • [29] Real-world costing analysis for diffuse large B-cell lymphoma in British Columbia
    Costa, S.
    Scott, D. W.
    Steidl, C.
    Peacock, S. J.
    Regier, D. A.
    CURRENT ONCOLOGY, 2019, 26 (02) : 108 - 113
  • [30] Treatment of elderly patients with diffuse large B-cell lymphoma
    Nösslinger T.
    memo - Magazine of European Medical Oncology, 2016, 9 (1) : 8 - 12
12345